JUPITER, Fla. — Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps Institute have designed a group of potential diabetes drugs that reprogram ...
Factors predicting long-term survival of hepatocellular carcinoma in developing country. This is an ASCO Meeting Abstract from the ASCO Breakthrough: A Global Summit for Oncology Innovators. This ...
T3D-959, an oral dual delta/gamma peroxisome proliferator-activated nuclear receptor (PPAR) agonist, has shown promise in a phase 2 randomized, placebo-controlled study of adults with mild-to-moderate ...
Obesity is one of the greatest burdens of global public health. One major factor that drives obesity is excessive fat accumulation. Despite decades of research, the biological processes that trigger ...
Scientists have designed potential new diabetes drugs that reprogram insulin-resistant cells. The new compounds target a protein called PPAR gamma, which regulates fat cell and insulin metabolism.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results